一、续聘会计师事务所事项的情况说明 立信会计师事务所（特殊普通合伙）（以下简称"立信"）具备从事证券业务 相关审计资格，具有多年为上市公司提供审计服务的经验与能力，已连续多年为 公司提供审计服务。在为公司提供审计服务的工作中，立信遵循相关法律、法规 和政策，遵照独立、客观、公正的执业准则，完成了公司2023年度财务报表和内 部控制审计工作，其出具的各项报告能够客观、公正、公允地反映公司财务情况 和经营结果，较好地履行了审计机构职责，从专业角度维护了公司及股东的合法 权益。 为保持审计工作的连续性，同意续聘立信为公司2024年度财务报表和内部控 制审计机构，聘期一年，审计费用由公司董事会提请股东大会授权公司管理层根 据年度审计工作量及市场价格水平协商确定。 二、续聘会计师事务所的基本信息 （一）机构信息 股票代码：002391 股票简称：长青股份 公告编号：2024-017 江苏长青农化股份有限公司 关于续聘会计师事务所的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 江苏长青农化股份有限公司（以下简称"公司"）于2024年4月16日召开第八 届董事会第十 ...

Financial Performance - The company's operating revenue for 2023 was approximately ¥3.61 billion, a decrease of 14.83% compared to ¥4.24 billion in 2022[13]. - Net profit attributable to shareholders was approximately ¥73.11 million, down 72.13% from ¥262.35 million in the previous year[13]. - The basic earnings per share decreased to ¥0.1126, a decline of 72.02% from ¥0.4024 in 2022[13]. - Total revenue for Q1 2023 was approximately CNY 1.02 billion, while Q4 2023 revenue decreased to about CNY 824.85 million, reflecting a decline of 19.3% from Q1[29]. - The net profit attributable to shareholders for Q4 2023 was a loss of approximately CNY 142 million, compared to a profit of CNY 90.41 million in Q1 2023, indicating a significant downturn[29]. - Non-recurring gains and losses totaled approximately CNY -12.68 million for 2023, compared to a gain of CNY 8.41 million in 2022, highlighting a deterioration in financial performance[31]. - The company's total operating cost for 2023 was approximately ¥2.7 billion, with the agricultural chemicals segment accounting for 87.85% of this cost, a 9.02% increase from the previous year[106]. - Financial expenses surged by 133.62% to ¥62,319,820.42, primarily due to increased bank loan interest and reduced foreign exchange gains[115]. - R&D expenses decreased by 13.91% to ¥174,402,822.21, representing 4.83% of total revenue[126]. Assets and Liabilities - The total assets at the end of 2023 were approximately ¥8.05 billion, an increase of 7.71% from ¥7.47 billion at the end of 2022[13]. - The net assets attributable to shareholders decreased slightly by 1.26% to approximately ¥4.58 billion from ¥4.64 billion in 2022[13]. - The total liabilities increased by 22.85% to CNY 346,955.50 million compared to the beginning of the year[71]. - The company's inventory accounted for 20.24% of total assets at the end of 2023, up from 19.07% at the beginning of the year[139]. - Short-term borrowings increased to 1,337,750,693.07 yuan, representing 16.62% of total assets, up from 11.09% at the beginning of the year[139]. Market and Industry Trends - The global pesticide market size grew from $35.575 billion in 2006 to $87.7 billion in 2022, with a compound annual growth rate of approximately 5.80%[26]. - The global agricultural chemical industry is experiencing consolidation, with major players like Syngenta and Bayer controlling over 60% of the market, which may impact competitive dynamics[33]. - The focus of the pesticide industry is shifting towards high-efficiency, low-toxicity, and low-residue new environmentally friendly pesticides, with new formulations like water-dispersible granules and controlled-release agents being rapidly developed and promoted[194]. - China is the world's largest pesticide exporter with 1,775 existing pesticide production enterprises, entering a new round of industry consolidation due to intensified competition and environmental pressures[191]. Production and Innovation - The company produced 30,390 tons of active ingredients in 2023, an increase of 46.51% year-on-year[71]. - The company has successfully introduced 30 new pesticide varieties with independent intellectual property rights, covering over 300 million mu of land, demonstrating its innovation capabilities[60]. - The company is focusing on the development of high-efficiency, low-toxicity, and low-residue new environmental-friendly pesticides as a key trend in the industry[169]. - The company has established multiple standardized production workshops to enhance production capacity and efficiency, ensuring high-quality products at competitive prices[95]. - The company has achieved production yield levels comparable to leading international pesticide companies, maintaining a high gross margin in its main business[97]. Sales and Marketing - Revenue from the pesticide segment was approximately ¥3.52 billion, accounting for 97.39% of total revenue, down 15.57% from ¥4.17 billion in 2022[81]. - Domestic sales reached CNY 170,491.06 million, reflecting a growth of 16.76% year-on-year[71]. - The company is focusing on enhancing its marketing strategies and expanding its international market presence[65]. - The company has a comprehensive marketing network covering all 30 provinces in China, enhancing its sales capabilities[108]. - The top five customers accounted for 44.46% of the total annual sales, indicating a significant reliance on a limited customer base[111]. Research and Development - The company plans to continue investing in R&D to enhance product offerings and maintain competitiveness in the market[84]. - The company’s R&D personnel increased by 6.40% to 366, with a notable rise in master's degree holders by 50.00%[126]. - The company is developing new products such as the "Fluazinam" and "Butyl Potassium," aiming for new profit growth points[123]. - The company is committed to increasing R&D investment to enhance the technological content and added value of pesticide products, aiming for a shift towards high-end product manufacturing[169]. Risks and Challenges - The company is facing risks related to industry competition, capacity expansion, and raw material price fluctuations, which could affect future performance[43]. - The company anticipates capacity expansion risks as new projects come online, which may not align with market demand, potentially affecting sales and profitability[179]. - Raw material price fluctuations pose a risk, as they account for approximately 70% of production costs, impacting the company's profitability despite its strong cost transfer capabilities[179]. - The company faces price competition risks due to the low market concentration in the pesticide industry, which may lead to declining product prices and profit margins[179]. - The company is subject to increasing regulatory pressures regarding environmental protection, which may raise operational costs and affect profitability[182]. Future Plans - The company aims for a revenue target of 4 billion yuan for 2024, representing a 10.67% increase compared to 2023[177]. - The company plans to expand its marketing team and enhance product structure to capture a larger share of the domestic formulation market[177]. - The company will focus on high-efficiency, low-toxicity, and low-residue pesticide research, production, and sales[177]. - The company intends to increase overseas registration of raw materials and formulations to build a global sales network[177]. - The company will prioritize safety management to ensure stable production operations across its facilities[177].

股票代码：002391 股票简称：长青股份 公告编号：2024-012 江苏长青农化股份有限公司 第八届董事会第十次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 江苏长青农化股份有限公司（以下简称"公司"）第八届董事会第十次会议 于 2024 年 4 月 16 日在公司会议室以现场方式召开，会议通知于 2024 年 3 月 25 日以通讯方式发送至公司全体董事、监事和高级管理人员。会议由董事长于国权 先生召集并主持，会议应到董事 7 名，现场参会董事 6 名，独立董事李钟华女士 以通讯方式出席本次会议，公司监事和部分高级管理人员列席了会议。本次会议 的召集、召开程序及出席会议的董事人数符合《公司法》和《公司章程》的规定。 经与会董事认真审议，本次会议以记名投票表决方式通过了以下决议： 一、审议通过了《2023 年度董事会工作报告》 2023 年，公司董事会严格按照法律法规、规范性文件及《公司章程》的规 定，本着对全体股东负责的态度，贯彻落实股东大会各项决议，全体董事恪尽职 守、勤勉尽职。 独立董事龚新海先生、李钟华女士、骆广生先生已向公司董事会 ...

一、监事会会议召开情况： 江苏长青农化股份有限公司 2023 年度监事会工作报告 2023年，江苏长青农化股份有限公司监事会依照《公司法》、《公司章程》 等法律法规有关规定，认真履行监督职责，积极维护全体股东的权益。 2023年度公司监事会共召开了三次会议，召开的情况如下： 2、2023年8月14日召开第八届监事会第七次会议，审议通过了以下议案： 报告期内，公司监事会按照《公司法》、《公司章程》的相关规定，认真开 展了监督工作： 1、公司依法运作情况 1、2023年4月10日召开了第八届监事会第六次会议，审议通过了以下议案： （1）《2022年度监事会工作报告》； （2）《2022年年度报告及其摘要》； （3）《2022年度财务决算报告》； （4）《2022年度利润分配预案》； （5）《2022年度内部控制自我评价报告》； （6）《2022年度募集资金存放与使用情况的专项报告》； （7）《2023年第一季度报告》； （8）《关于继续使用暂时闲置募集资金进行现金管理的议案》； （9）《关于续聘会计师事务所的议案》。 （10）《关于部分募集资金投资项目结项并将节余募集资金永久补充流动资 金的议案》。 （1）审议《 ...

江苏长青农化股份有限公司 未来三年（2024年—2026年）股东回报规划 （2024 年 4 月 16 日第八届董事会第十次会议制订） 江苏长青农化股份有限公司（以下简称"公司"）为了健全和完善利润分配的 决策和监督机制，向股东提供持续、合理、稳定的投资回报，引导投资者树立长期 投资和理性投资理念，根据中国证监会《关于进一步落实上市公司现金分红有关事 项的通知》（证监发[2012]37号）、《上市公司监管指引第3号—上市公司现金分 红》（证监会公告（2023）61号）等相关法律、法规、规范性文件以及《公司章程》 的相关规定，结合公司实际情况，特制订公司《未来三年（2024年—2026年）股东 回报规划》（以下简称"本规划"）。 一、本规划考虑的因素 公司着眼于长远和可持续的发展，在综合考量公司所处行业特点、发展阶段、 自身经营模式、发展规划、盈利能力、资金状况、社会资金成本、外部融资环境等 重要因素，以及平衡股东的合理投资回报和公司长远发展的基础上，建立对投资者 持续、稳定、科学的回报规划与机制，以保证利润分配政策的合理性、连续性和稳 定性。 二、本规划制订的原则 1、本规划的制订应符合相关法律、法规和规范性 ...

Financial Performance - The company's revenue for Q1 2024 was ¥859,885,614.78, a decrease of 15.84% compared to ¥1,021,723,217.16 in the same period last year[18] - Net profit attributable to shareholders was ¥7,903,609.81, down 91.26% from ¥90,412,091.70 year-on-year[18] - Basic earnings per share decreased by 91.20% to ¥0.0122 from ¥0.1387 in the same period last year[18] - Total operating revenue for the first quarter was ¥859,885,614.78, a decrease of 15.8% compared to ¥1,021,723,217.16 in the previous period[41] - The company's net profit for the current period is 7,902,233.59, a significant decrease from 90,806,000.14 in the previous period[43] - Total profit for the current period is 7,497,716.12, compared to 11,404,219.09 in the previous period, reflecting a decline[43] Cash Flow - The net cash flow from operating activities was -¥135,368,776.32, representing a decline of 404.58% compared to -¥26,827,951.45 in the previous year[18] - The net cash flow from operating activities decreased by 404.58% to -135,368,776.32 RMB, primarily due to a reduction in cash received from sales of goods and services[22] - Cash inflow from investment activities totaled ¥387,707,436.70, a decrease of 53.8% from ¥839,285,363.82 in the prior year[31] - Cash outflow from investment activities was ¥636,239,541.01, down 41.0% from ¥1,079,413,672.29 in the previous period[31] - The company reported a net cash flow from investment activities of -¥248,532,104.31, slightly worse than -¥240,128,308.47 in the prior year[31] - The net cash flow from financing activities is 384,620,801.97, an increase from 149,676,724.00 in the previous period[45] - The company reported a net cash outflow of -2,287,519.12, compared to -118,104,172.68 in the previous period[45] Assets and Liabilities - Total assets increased by 6.87% to ¥8,603,884,459.82 from ¥8,050,482,608.58 at the end of the previous year[18] - The total liabilities increased to 2,727,079,753.88 RMB, compared to 1,647,924.48 RMB, indicating a significant rise in financial obligations[25] - Long-term borrowings increased by 63.12% to ¥1,106,869,434.61, attributed to loans for fixed asset projects and long-term working capital[21] - Long-term borrowings increased to ¥1,106,869,434.61 from ¥678,559,932.82, reflecting a significant rise in debt[41] - Total liabilities rose to ¥4,059,141,283.93, compared to ¥3,469,554,960.86 in the previous period, indicating increased financial leverage[41] Investments and Fair Value - The company reported a significant increase of 3679.32% in fair value gains to ¥5,313,779.56, mainly due to the settlement of forward foreign exchange contracts[21] - The company reported a fair value change gain of 5,313,779.56, contrasting with a loss of 148,457.76 in the previous period[43] - The company’s investment income showed a loss of -1,679,239.17, a decline from a gain of 5,098,629.92 in the previous period[43] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 27,532, with the largest shareholder holding 25.40% of the shares[22] - The company’s total equity decreased to ¥4,544,743,175.89 from ¥4,580,927,647.72, showing a slight decline in shareholder value[41] Other Financial Metrics - The company recorded a net loss of ¥2,344,240.60 from non-recurring gains and losses, primarily due to charitable donations[18] - The company incurred interest expenses of 20,569,574.65, up from 18,707,765.75 in the previous period[43] - The company experienced a credit impairment loss of -5,451,947.26, worsening from -1,530,930.35 in the previous period[43] - The company’s cash and cash equivalents decreased to 387,936,348.37 RMB from 401,678,123.47 RMB, a decline of approximately 3.67%[24] - The inventory balance increased to 1,753,600,956.26 RMB, up from 1,629,224,554.92 RMB, reflecting a growth of about 7.63%[24] - The company’s long-term equity investments decreased slightly to 22,696,100.00 RMB from 24,694,100.00 RMB, a decline of about 8.09%[25] - The company’s income tax expense decreased by 142.27% to -3,919,970.93 RMB, primarily due to a decline in profits[22]

江苏长青农化股份有限公司董事会 关于 2023 年度内部控制自我评价报告 江苏长青农化股份有限公司董事会 关于 2023 年度内部控制自我评价报告 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称 "企业内部控制规范体系"），结合江苏长青农化股份有限公司（以下简称"公司"）内部 控制制度和评价方法，在内部控制日常监督和专项监督的基础上，我们对公司截至 2023 年 12 月 31 日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一、重要声明 公司内部控制的目标：建立和完善符合现代企业管理要求的内部组织架构，形成科学的决 策机制、执行机制和监督机制；建立行之有效的内部控制系统，强化风险管理，保证公司 各项业务活动的正常有序运行；严格遵守国家有关法律法规和行业规章，自觉形成守法经 营、规范运作的经营思想；预防和控制各种错误和弊端的发生，消除隐患，合理保证经营 管理合法合规、资产安全、财务报告及相关信息真实完整，提高经营效率和效果，促进公 司经营目标和发展战略的实现。由于内部控制存在的固有局限性，故仅能为实现上述目标 提供合理保证。此外，由于情况的变化可能导致内部控制变得不恰 ...

江苏长青农化股份有限公司 独立董事 2023 年度述职报告 （龚新海） 尊敬的各位股东： 作为江苏长青农化股份有限公司（以下简称"公司"）独立董事，2023年度， 根据《公司法》、《上市公司独立董事管理办法》、《关于加强社会公众股股东 权益保护的若干规定》、《上市公司自律监管指引第1号——主板上市公司规范 运作》等法律和其他规范性文件，以及《公司章程》、《独立董事工作制度》的 规定和要求，恪尽职守、勤勉尽责，积极出席相关会议，认真审议董事会各项议 案，对公司相关事项发表独立意见，充分发挥独立董事的独立作用，切实维护公 司和股东，尤其是中小股东的利益。现将2023年度本人履职情况汇报如下： 一、出席会议情况 本人本着勤勉尽责的态度积极参加公司2023年度召开的董事会和股东大会， 在会议召开之前均主动了解并获取作出决策所需要的情况和资料，了解公司生产 运作和经营情况，会议上认真审阅每项议案，积极参与各项议题的讨论并提出合 理化建议，为董事会作出正确、科学的决策发挥积极作用。 2023年，公司董事会、股东大会的召集召开符合法定程序，重大经营决策事 1 项均履行了相关程序，合法有效。本人对各次董事会会议审议的相关议案 ...

江苏长青农化股份有限公司 审计报告及财务报表 （2023 年 01 月 01 日至 2023 年 12 月 31 日止） | | 目录 | 页次 | | --- | --- | --- | | 一、 | 审计报告 | 1-6 | | 二、 | 财务报表 | | | | 合并资产负债表和母公司资产负债表 | 1-4 | | | 合并利润表和母公司利润表 | 5-6 | | | 合并现金流量表和母公司现金流量表 | 7-8 | | | 合并所有者权益变动表和母公司所有者权益变动表 | 9-12 | | | 财务报表附注 | 1-111 | 审计报告 信会师报字[2024]第 ZH10080 号 江苏长青农化股份有限公司全体股东： 一、 审计意见 我们审计了江苏长青农化股份有限公司（以下简称"长青股份"） 财务报表，包括 2023 年 12 月 31 日的合并及母公司资产负债表，2023 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公 司所有者权益变动表以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的 规定编制，公允反映了长青股份 2023 年 12 月 31 日的合并 ...

江苏长青农化股份有限公司 2023年度募集资金存放与使用情况专项报告 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求（2022 年修订）》（证监会公告〔2022〕15 号）、 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》以 及《深圳证券交易所上市公司自律监管指南第 2 号——公告格式》的相关规定， 本公司就 2023 年度募集资金存放与使用情况作如下专项报告： 一、 募集资金基本情况 经中国证券监督管理委员会《关于核准江苏长青农化股份有限公司公开发行 可转换公司债券的批复》（证监许可[2018]2097 号）核准，公司于 2019 年 2 月 27 日向社会公开发行 913.8 万张可转换公司债券，每张面值 100 元，公开发行可 转债募集资金总额为 913,800,000.00 元，扣除承销费、保荐费等发行费用 21,047,380.00 元后，本次募集资金净额为 892,752,620.00 元。募集资金到位情况 业经立信会计师事务所（特殊普通合伙）验证，并 2019 年 3 月 5 日出具了信会 师报字[2019]第 ZH10 ...